Most-favored-nation pricing is “founded on incorrect assumptions about where high out-of-pocket costs really come from and what it would mean for the US to adopt cost-effectiveness standards used by ...

Rigorous answers about the program’s effects on drug innovation are still a ways off. However, some information about ...

Trump's executive order on drug prices gives no information on actual price targets and it doesn't disclose a plan for how to ...